COVID-19 Vaccine Hesitancy Among Nurses

July 7, 2024 updated by: National Taiwan University Hospital
The purpose of this study is to investigate the correlation of intention to receive COVID-19 vaccine, recommendation behavior, and 5C psychological antecedents among Nurses. The results can be used to assist suggestions in the health education provided by nurses on the topic of COVID-19 pneumonia and its vaccination. The purpose of the study is also wants to build a basis for future research and public support in vaccine decision-making, as well as to enhance the promotion of vaccine policy and enhance the resilience of the whole population during the pandemic ear.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

A cross-sectional study based on convenience samples. The investigators recruit nurses and the general public to respond to structured self-filling electronic questionnaires by using an electronic data collection system. The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items. Convenience sampling was applied to estimate the sample size according to the number of nurses in each county. It is planned to collect a total of 4258 responses by the end of the study. The study instrument is the 5C psychological antecedents of vaccination, which includes Confidence, Complacency, Constraints, Calculation, and Collective Responsibility.

Study Type

Observational

Enrollment (Actual)

4258

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Department of Nursing, National Taiwan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

[Nurses] Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license.

[General publics] Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.

Description

[Nurses]

Inclusion Criteria:

  • Male and female participants must be ≥ 20 years at the time of informed consent.
  • Male and female participants have verification of registered nurse license.

Exclusion Criteria:

  • Male and female participants be>80 years at the time of informed consent.

[General publics]

Inclusion Criteria:

  • Male and female participants must be ≥ 20 years at the time of informed consent.
  • Male and female participants have reading abilities above the intermediate level.

Exclusion Criteria:

  • Male and female participants be>80 years at the time of informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Nurses
Adult (≥ 20 and ≤80 years) male and female participants with verification of registered nurse license.
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.
General publics
Adult (≥ 20 and ≤80 years) male and female participants with reading abilities above the intermediate level.
The questionnaires include demographic data and vaccine hesitancy questions in a total of 35 items.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The correlation of intention to receive COVID-19 vaccine and 5C psychological antecedents (5C scale) among nurses and general publics.
Time Frame: The questionnaire length around 10 minutes.
The 5C scale measures the psychological antecedents of vaccination, using 15 item tools including 5 domains (confidence, complacency, constraints, calculation, and collective responsibility). Each domain was assessed by 3 rating items on a 7-point scale (1=strongly disagree; 7=strongly agree). The mean scores of items under each domain were computed, with a higher average score indicating stronger agreement of the corresponding domain.
The questionnaire length around 10 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jung-Chen Chang, Ph.D, Department of Nursing, National Taiwan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2022

Primary Completion (Actual)

May 19, 2022

Study Completion (Actual)

May 19, 2022

Study Registration Dates

First Submitted

January 24, 2022

First Submitted That Met QC Criteria

January 24, 2022

First Posted (Actual)

January 28, 2022

Study Record Updates

Last Update Posted (Actual)

July 9, 2024

Last Update Submitted That Met QC Criteria

July 7, 2024

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Questionnaires

Subscribe